AP
GMED icon

AHL Partners’s Globus Medical GMED Stock Holding History

AHL Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$8.36M Sell
203,408
-51,865
-20% -$1.82M 0.13% 276
2017
Q3 		$7.59M Sell
255,273
-162,806
-39% -$4.97M 0.14% 267
2017
Q2 		$13.9M Buy
418,079
+20,771
+5% +$652K 0.29% 42
2017
Q1 		$11.8M Buy
397,308
+285,935
+257% +$7.8M 0.26% 61
2016
Q4 		$2.76M Sell
111,373
-63,949
-36% -$1.45M 0.08% 421
2016
Q3 		$3.96M Sell
175,322
-24,403
-12% -$574K 0.15% 219
2016
Q2 		$4.76M Buy
199,725
+171,457
+607% +$4.11M 0.26% 86
2016
Q1 		$671K Sell
28,268
-26,324
-48% -$644K 0.04% 492
2015
Q4 		$1.52M Sell
54,592
-14,822
-21% -$372K 0.12% 316
2015
Q3 		$1.43M Sell
69,414
-162,194
-70% -$4.11M 0.23% 167
2015
Q2 		$5.95M Buy
231,608
+850
+0.4% +$21.5K 0.24% 115
2015
Q1 		$5.82M Buy
230,758
+20,494
+10% +$499K 0.23% 111
2014
Q4 		$5M Sell
210,264
-59,860
-22% -$1.33M 0.26% 59
2014
Q3 		$5.31M Buy
+270,124
New +$5.56M 0.41% 42

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AHL Partners's GMED Position: Q4 2017 in Review

AHL Partners reduced its Globus Medical (GMED) stake by 20% in Q4 2017, selling an estimated $1.82M and leaving 203,408 shares worth $8.36M. The position accounts for 0.13% of the portfolio, ranked #276.

AHL Partners first reported a position in GMED in Q3 2014 and has held it in 14 quarters since. The position peaked at $13.9M in Q2 2017. 263 funds tracked by Wall St. Rank hold GMED as of Q4 2017.

  • AHL Partners held 203,408 shares of Globus Medical worth $8.36M as of Q4 2017.
  • AHL Partners sold 51,865 Globus Medical shares in Q4 2017, an estimated $1.82M.
  • Globus Medical made up 0.13% of AHL Partners's portfolio in Q4 2017, its #276 holding.
  • AHL Partners first reported a position in Globus Medical in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Globus Medical position peaked at $13.9M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held Globus Medical as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.